Literature DB >> 29524138

Purified Protein Delivery to Activate an Epigenetically Silenced Allele in Mouse Brain.

Benjamin Pyles1, Barbara J Bailus1,2, Henriette O'Geen1, David J Segal3.   

Abstract

The ability to activate or repress specific genes in the brain could have a tremendous impact for understanding and treating neurological disorders. Artificial transcription factors based on zinc finger, TALE, and CRISPR/Cas9 programmable DNA-binding platforms have been widely used to regulate the expression of specific genes in cultured cells, but their delivery into the brain represents a critical challenge to apply such tools in live animals. In previous work, we developed a purified, zinc finger-based artificial transcription factor that could be injected systemically, cross the blood-brain barrier, and alter expression of a specific gene in the brain of an adult mouse model of Angelman syndrome. Importantly, our mode of delivery produced widespread distribution throughout the brain. Here we describe our most current methods for the production and purification of the factor, dosage optimization, and use of live animal fluorescence imaging to visualize the kinetics of distribution.

Entities:  

Keywords:  Animal models; Engineered zinc finger protein; Gene therapy; Neurologic disease; Preclinical studies

Mesh:

Substances:

Year:  2018        PMID: 29524138      PMCID: PMC6281562          DOI: 10.1007/978-1-4939-7774-1_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.

Authors:  Maarja Mäe; Ulo Langel
Journal:  Curr Opin Pharmacol       Date:  2006-07-24       Impact factor: 5.547

2.  Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain.

Authors:  Cassia N Cearley; John H Wolfe
Journal:  Mol Ther       Date:  2006-01-18       Impact factor: 11.454

Review 3.  Protein transduction: cell penetrating peptides and their therapeutic applications.

Authors:  Kylie M Wagstaff; David A Jans
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

4.  The generation of zinc finger proteins by modular assembly.

Authors:  Mital S Bhakta; David J Segal
Journal:  Methods Mol Biol       Date:  2010

5.  Protein delivery using Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu; Kimberly E Anderson; Shannon J Sirk; Carlos F Barbas
Journal:  ACS Chem Biol       Date:  2014-06-19       Impact factor: 5.100

6.  Design, Assembly, and Characterization of TALE-Based Transcriptional Activators and Repressors.

Authors:  Pratiksha I Thakore; Charles A Gersbach
Journal:  Methods Mol Biol       Date:  2016

Review 7.  Editing the epigenome: technologies for programmable transcription and epigenetic modulation.

Authors:  Pratiksha I Thakore; Joshua B Black; Isaac B Hilton; Charles A Gersbach
Journal:  Nat Methods       Date:  2016-02       Impact factor: 28.547

8.  Highly active zinc-finger nucleases by extended modular assembly.

Authors:  Mital S Bhakta; Isabelle M Henry; David G Ousterout; Kumitaa Theva Das; Sarah H Lockwood; Joshua F Meckler; Mark C Wallen; Artem Zykovich; Yawei Yu; Heather Leo; Lifeng Xu; Charles A Gersbach; David J Segal
Journal:  Genome Res       Date:  2012-12-05       Impact factor: 9.043

9.  Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators.

Authors:  Lauren R Polstein; Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Peggy Bledsoe; Lingyun Song; Alexias Safi; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Genome Res       Date:  2015-05-29       Impact factor: 9.043

10.  Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain.

Authors:  Barbara J Bailus; Benjamin Pyles; Michelle M McAlister; Henriette O'Geen; Sarah H Lockwood; Alexa N Adams; Jennifer Trang T Nguyen; Abigail Yu; Robert F Berman; David J Segal
Journal:  Mol Ther       Date:  2016-01-04       Impact factor: 11.454

View more
  2 in total

1.  Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells.

Authors:  Anna Adhikari; Nycole A Copping; Julie Beegle; David L Cameron; Peter Deng; Henriette O'Geen; David J Segal; Kyle D Fink; Jill L Silverman; Joseph S Anderson
Journal:  Hum Mol Genet       Date:  2021-06-09       Impact factor: 6.150

Review 2.  Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.

Authors:  Nycole A Copping; Stephanie M McTighe; Kyle D Fink; Jill L Silverman
Journal:  Neurotherapeutics       Date:  2021-09-15       Impact factor: 7.620

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.